Related references
Note: Only part of the references are listed.Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
Margareta Heby et al.
BMC CLINICAL PATHOLOGY (2015)
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer A dual-institutional follow-up with the RTOG 9704 trial
Florencia McAllister et al.
CANCER BIOLOGY & THERAPY (2014)
Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma
Jacob Elebro et al.
DIAGNOSTIC PATHOLOGY (2014)
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
William Greenhalf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
Jacob Elebro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Clinical significance of HuR expression in human malignancy
Ioly Kotta-Loizou et al.
MEDICAL ONCOLOGY (2014)
Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
Richard Fristedt et al.
PLOS ONE (2014)
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
Elizabeth Poplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Meta-Analysis of Gemcitabine Biomarkers in Patients With Pancreaticobiliary Cancers
Christina H. Wei et al.
PANCREAS (2013)
DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
Yuriko Saiki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
Raphael Marechal et al.
GASTROENTEROLOGY (2012)
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes
G. Perrone et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2010)
Tissue Microarray Analysis of 560 Patients with Colorectal Adenocarcinoma: High Expression of HuR Predicts Poor Survival
Peter S. Yoo et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
Christina L. Costantino et al.
CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
Diverse molecular functions of Hu proteins
M. N. Hinman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer
D. Santini et al.
ANNALS OF ONCOLOGY (2008)
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR
J Mrena et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
